文献速递乳腺介入USMR

超声引导冷冻消融治疗不适合或拒绝手术的乳腺癌:单中心经验

Ultrasound-guided cryoablation for breast cancer ineligible for or refused surgery: a single-center experience.
PubMed 文献 · Clin Radiol · 2025-11-26

回顾性纳入2020年4月至2023年4月不适合或拒绝手术的乳腺癌女性,行超声引导冷冻消融及适当辅助治疗,主要终点为对比增强超声和动态对比增强磁共振成像按mRECIST评估的肿瘤进展。17例成功消融患者平均随访27.8个月,完全缓解率100%,无严重并发症,作者认为该治疗安全可行。

要点

  • 超声引导冷冻消融后按mRECIST评估完全缓解率达100%,随访平均27.8个月。
  • 仅17.6%(3/17)患者报告轻度疼痛,无严重操作相关并发症。
  • 美容满意度达100%,16例接受辅助内分泌治疗。

核心结论

  • 作者认为,超声引导冷冻消融对不适合或拒绝手术的乳腺癌女性是一种安全且可行的治疗。

研究设计与样本

  • 单中心回顾性研究,纳入2020年4月至2023年4月不适合或拒绝手术的乳腺癌女性17例,行超声引导冷冻消融及适当辅助治疗,主要评估指标为对比增强超声和动态对比增强磁共振成像按mRECIST评估的肿瘤进展。

诊断标准与关键数值

  • 完全缓解率100%,以对比增强超声和动态对比增强磁共振成像按mRECIST评估;中位肿瘤直径1.79 cm(四分位距0.91-3.30 cm);平均随访27.8个月(范围12-36个月)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate the safety and feasibility of ultrasound-guided cryoablation for breast cancer in patients ineligible for or who refused surgery.

MATERIALS AND METHODS: In this retrospective study, women with breast cancer who were ineligible for or refused surgery underwent ultrasound-guided cryoablation and adjuvant therapy, as appropriate, from April 2020 to April 2023 and were included. The primary evaluation criterion was tumor progression assessed by mRECIST on both contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging. Pain assessment using visual analog scale, complications, and cosmetic satisfaction were also evaluated.

RESULTS: Seventeen patients receiving successful cryoablation were included in the study, and 16 received adjuvant endocrine therapy. The mean age was 70 ± 9 years. The median tumor diameter was 1.79 cm (interquartile range, 0.91-3.30 cm). During a mean follow-up period of 27.8 months (range, 12-36 months), the complete response rate was 100 %. Mild pain was indicated in 17.6 % (3/17) of patients using the visual analog scale. No severe procedure-related complications were reported, and cosmetic satisfaction reached 100 %.

CONCLUSION: According to the results of the current study, ultrasound-guided cryoablation for breast cancer is a safe and feasible treatment in women who are ineligible for or refuse surgery.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Ye YY, Zhang Q, Zeng CH, et al. Ultrasound-guided cryoablation for breast cancer ineligible for or refused surgery: a single-center experience. Clin Radiol. 2025. PMID: 41423394. doi:10.1016/j.crad.2025.107191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。